Celiac Disease: Diagnostic Standards and Dilemmas

Area of Science:

• Gastroenterology
• Immunology
• Genetics

Background:

• Celiac disease (CD) affects over 1% of the population, with increasing prevalence.
• Variable presentations necessitate high physician awareness and a low threshold for testing.
• Advances in understanding pathogenesis drive the development of new diagnostic tools.

Purpose of the Study:

• To review the history and current diagnostic approaches for celiac disease.
• To provide guidance for evaluating celiac disease in complex diagnostic scenarios.
• To highlight the importance of early and accurate diagnosis.

Main Methods:

• Review of current literature on celiac disease diagnosis.
• Discussion of serological assays: Endomysial Antibody (EMA), tissue transglutaminase (tTG), and Deamidated Gliadin Peptide (DGP).
• Inclusion of genetic testing (HLA DQ2/DQ8) and gluten challenge refinement in diagnostic algorithms.

Main Results:

• Highly sensitive and specific serological assays simplify celiac disease testing.
• Genetic testing for HLA DQ2 and DQ8 is increasingly available.
• Diagnosis can be challenging in specific populations (e.g., IgA deficiency, young children, pre-dietary changes).

Conclusions:

• Current diagnostic tools, including serology and genetics, have significantly advanced celiac disease identification.
• Physicians must remain vigilant for atypical presentations and high-risk individuals.
• Guidance is provided for managing difficult diagnostic circumstances to ensure timely diagnosis and treatment.